ClinXus is a non-profit community based alliance established in West Michigan to enable biomarker driven and innovative clinical trial designs as recently defined by the United States Food and Drug Administration (FDA) and European regulatory agencies. The alliance is comprised of existing community health care, clinical, research, and educational organizations. It seeks to establish a 21st Century “open-architecture” biomarker driven clinical trials network to serve the increasingly molecular-based medical applications. The ClinXus network is dedicated to improvement of the clinical trial process by applying solutions and services related to innovative patient access, biomarker implementation and trial designs.

Coupled with the strengths and expertise of the organizations involved ClinXus acts as the single point of contact to extend the following coordinated community capabilities and services:

  • Protocol and project design, development and implementation [-]
    •
    • Phase I-IV expertise, trial design and coordination
      •
    • Research coordinators/support staff
      •
    • Educational forums for physicians, health care partners and communities
      •
    • Regulatory/compliance consultation
      •
    • Tissue collection and biobanking facilities
      •
  • State of the art patient facilities and support [-]
    •
    • Combined hospital capacity of over 1,500 beds
      •
    • 50 bed full service Phase I clinical research unit
      •
    • Access to a well characterized 1.4 million patient population
      •
    • Integrated physician network (with extensive Electronic Medical Record (EMR) utility)
      •
    • Standardized and custom sample acquisition
      •
  • Extensive molecular profiling capability [-]
    •
    • Advanced imaging and molecular profiling platforms for biomarker discovery and qualification
      •
    • Discovery core services (including preclinical)
      •
    • The Center for Molecular Medicine (CMM) – a high complexity CLIA/CAP accredited organization focused on the development and application of molecular-based diagnostics
      •
  • Full breadth of integrated IT infrastructure [-]
    •
    • Data management services, including data and image warehousing
      •
    • Molecular analysis, interpretation and reporting services
      •
    • Conventional and Exploratory Statistical services, including modeling and simulation, PK/PD analyses
      •
    • Target data assembly from diverse discovery and pre-clinical sources across therapeutic areas

News - ClinXus Joins International Critical Path Institute Consortium
Click here to learn more about ClinXus

 
     
 
 
     
 

Our Founding Members: